Human Genome Anthrax Drug
Links shared publicly online about this topic
More study needed on Human Genome anthrax drug | Lifescript.com
lifescript.com — “SILVER SPRING (Reuters) - More evidence is needed to show a proposed Human Genome Sciences Inc drug...” View full resource at lifescript.com
Most Recently Shared on October 28, 2009 at 2:32 am By:
More study needed on Human Genome anthrax drug http://twurl.nl/lazfpi
U.S. panel: More study on Human Genome anthrax drug | Reuters
feeds.reuters.com — “SILVER SPRING, Maryland (Reuters) - Animal data suggests a proposed Human Genome Sciences Inc drug may help people exposed to anthrax but more study is needed to show the treatment adds benefit beyond” View full resource at feeds.reuters.com
Most Recently Shared on October 27, 2009 at 10:57 pm By:
U.S. panel: More study on Human Genome anthrax drug http://link.reuters.com/nug36f
FDA questions delay approval of Human Genome Sciences anthrax drug raxibacumab - washingtonpost.com
washingtonpost.com — “anthrax treatment delayed by FDA” View full resource at washingtonpost.com
Most Recently Shared on November 16, 2009 at 11:28 pm By:
FDA delays approval of Rockville company's anthrax drug - Washington Post http://ow.ly/1628yh
FDA questions Human Genome drug - washingtonpost.com
washingtonpost.com — “Human Genome Sciences's experimental anthrax treatment, studied more extensively in animals than in humans, may not be more effective than older therapies, the Food and Drug Administration said Friday.” View full resource at washingtonpost.com
Most Recently Shared on October 24, 2009 at 6:48 am By:
FDA questions Human Genome drug - Washington Post http://bit.ly/2LxAWl
New Drug Fights Anthrax Toxin - Drugs.com MedNews
drugs.com — “Scientists report that experiments in animals show that a new, monoclonal antibody drug might safely cure anthrax poisoning in humans. Although antibiotics can ” View full resource at drugs.com
Most Recently Shared on July 8, 2009 at 11:12 pm By:
HUMAN GENOME SCIENCES RECEIVES COMPLETE RESPONSE LETTER FROM FDA FOR RAXIBACUMAB BIOLOGICS LICENSE APPLICATION - HGS
hgsi.com — “Human Genome Sciences is an emerging pharmaceutical company with the mission to predict, prevent, detect, treat and cure disease.” View full resource at hgsi.com
Most Recently Shared on November 16, 2009 at 1:28 pm By:
HUMAN GENOME SCIENCES RECEIVES COMPLETE RESPONSE LETTER FROM FDA FOR RAXIBACUMAB FOR ANTHRAX TRMT - http://ow.ly/CJhC
Data Published in the New England Journal of Medicine Support Use of Raxibacumab (ABthrax (TM)) for the Treatment of Inhalation Anthrax
newswise.com — “Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced publication by The New England Journal of Medicine of the results of two pivotal animal efficacy studies, which showed the life-saving potential of the Company's human monoclonal antibody drug raxibacumab (ABthrax (TM)), as well as the results of human safety studies, which supported the use of raxibacumab in the event of life-threatening inhalation anthrax disease.” View full resource at newswise.com
Most Recently Shared on July 9, 2009 at 11:53 am By:
Data Published in the New England Journal of Medicine Support Use of Raxibacumab (ABthrax (TM)) for the Treatmen.. http://bit.ly/9lPIq
Anthrax drug could thwart terrorists | Booster Shots | Los Angeles Times
latimesblogs.latimes.com — “An experimental drug called raxibacumab protected monkeys and rabbits against inhaled anthrax and could presumably be used to protect humans in the event of a terrorist attack, researchers reported today in the New England Journal of Medicine. Anthrax can be...” View full resource at latimesblogs.latimes.com
Most Recently Shared on July 9, 2009 at 12:30 am By:
Big Human Genome lupus drug nears market
health.yahoo.net — “Human Genome Sciences Inc's lupus drug is poised to win clearance this week, offering patients the first approved treatment option in a half-century and setting the company up for blockbuster sales.” View full resource at health.yahoo.net
Most Recently Shared on March 7, 2011 at 7:40 pm By:
Big Human Genome lupus drug nears U.S. market: Human Genome Sciences Inc's lupus drug is poised to win U.S. clea... http://bit.ly/96NLdu
Advisers recommend Human Genome lupus drug | Reuters
reuters.com — “ADELPHI, Maryland (Reuters) - The first new lupus treatment in half a century moved closer to U.S. approval on Tuesday as an advisory panel endorsed a potential blockbuster medicine from Human Genome Sciences” View full resource at reuters.com
Most Recently Shared on November 17, 2010 at 1:41 am By:
Advisers recommend Human Genome lupus drug http://dlvr.it/8fsfd
Big Human Genome lupus drug nears market
health.yahoo.net — “Human Genome Sciences Inc's lupus drug is poised to win clearance this week, offering patients the first approved treatment option in a half-century and setting the company up for blockbuster sales.” View full resource at health.yahoo.net
Most Recently Shared on March 7, 2011 at 7:32 pm By:
Big Human Genome lupus drug nears U.S. market http://bit.ly/9HCyFu
Advisers recommend Human Genome lupus drug | Reuters
reuters.com — “ADELPHI, Maryland (Reuters) - The first new lupus treatment in half a century moved closer to U.S. approval on Tuesday as an advisory panel endorsed a potential blockbuster medicine from Human Genome Sciences” View full resource at reuters.com
Most Recently Shared on November 17, 2010 at 1:46 am By:
Advisers recommend Human Genome lupus drug: ADELPHI, Maryland (Reuters) - The first new lupus treatment in half ... http://bit.ly/ceu2Eg
Will The Human Genome Lupus Drug Pass Muster? // Pharmalot
pharmalot.com — “Will The Human Genome Lupus Drug Pass Muster? // Pharmalot” View full resource at pharmalot.com
Most Recently Shared on November 12, 2010 at 3:12 pm By:
RT @pharmalot: Will The Human Genome Lupus Drug Pass Muster? http://bit.ly/cfjSiO
Regulators question HGS drug; Gilead gets panel review date; - FierceBiotech
fiercebiotech.com — “> In anticipation of an upcoming FDA panel review, regulators questioned the efficacy of Human Genome Science's anthrax drug and asked if it truly works better than existing therapies. Story >... Read more...” View full resource at fiercebiotech.com
Most Recently Shared on October 26, 2009 at 6:46 pm By:
Regulators question HGS drug; Gilead gets panel review date; http://bit.ly/kdV2c
Human Genome lupus drug draws questions; stock off | Reuters
reuters.com — “WASHINGTON (Reuters) - U.S. drug reviewers asked if the benefits of a long-awaited Human Genome Sciences Inc lupus drug outweighed concerns about suicide and other possible risks, but analysts said they” View full resource at reuters.com
Most Recently Shared on November 12, 2010 at 6:52 pm By:
Human Genome lupus drug draws questions; stock off: WASHINGTON (Reuters) - U.S. drug reviewers asked if the bene... http://bit.ly/bIH4mv
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
LifeScript
Living healthy should be practical, shouldn't it? Laurie S. tweeting with you today. ...
-
Reuters Health
-
Health Feed
Heath News & Information
Advertisement

